Drug & intervention

droxidopa

RxCUI 1489913

Clinical trials15
Recruiting1
Related conditions20
Synonyms1

RxNorm ingredient and formulation relationships

Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.

Loading RxNorm relationships…

Clinical trials

15 shown
Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic FailureNCT02897063 · 2016-09-01
RECRUITING
Safety and Efficacy of Droxidopa for Fatigue in Patients With ParkinsonismNCT03446807 · 2021-12-01
WITHDRAWN
Brain Perfusion & Oxygenation in Parkinson's Disease With NOHNCT03229174 · 2018-08-23
COMPLETED
Effect of L-Dihydroxyphenylserine (L-DOPS) on Falls in Patients With Neurogenic Orthostatic Hypotension (NOH)NCT03567447 · 2018-08-17
UNKNOWN
Norepinephrine-targeted Therapy for Action Control in Parkinson DiseaseNCT03115827 · 2017-04-18
COMPLETED
Effects of Droxidopa When Measuring Gait Speed, Kyphosis, and Functional Reach in Parkinson's DiseaseNCT03173781 · 2016-04-01
COMPLETED
Study to Assess the Clinical Benefit and Safety of Droxidopa in Parkinson's DiseaseNCT02066571 · 2015-03-01
UNKNOWN
A Clinical Study of Patients With Symptomatic NOH to Assess Sustained Effects of Droxidopa TherapyNCT01927055 · 2013-11-01
TERMINATED
Study to Assess Droxidopa in the Treatment of Freezing Of Gait Symptoms in Patients With Parkinson's DiseaseNCT01331122 · 2012-04-01
WITHDRAWN
Droxidopa / Pyridostigmine in Orthostatic HypotensionNCT01370512 · 2011-11-01
ENROLLING_BY_INVITATION
A Two Part Study (306A/306B) to Assess Droxidopa in Treatment of NOH in Patients With Parkinson's DiseaseNCT01176240 · 2010-06-01
COMPLETED
A Clinical Study for Patients With Neurogenic Orthostatic Hypotension (NOH) Using DroxidopaNCT00782340 · 2008-09-01
COMPLETED
Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH)NCT00633880 · 2008-01-01
COMPLETED
Open-Label Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH)NCT00738062 · 2008-01-01
COMPLETED
Augmenting Effects of L-DOPS With Carbidopa and EntacaponeNCT00547911 · 2007-10-01
TERMINATED

Conditions being studied

Parkinson Disease6Dopamine Beta Hydroxylase Deficiency4Multiple System Atrophy4Parkinson's Disease4Orthostatic Hypotension3Neurogenic Orthostatic Hypotension2Non-diabetic Neuropathy2Primary Autonomic Failure2Pure Autonomic Failure2Symptomatic Neurogenic Orthostatic Hypotension (NOH)2Autonomic Failure1Autonomic Nervous System Diseases1Cognitive Ability, General1Falls Patient1Freezing of Gait1Gait Disorders, Neurologic1Multiple Systems Atrophy1Non-Diabetic Autonomic Neuropathy1Progressive Supranuclear Palsy1Symptomatic Neurogenic Orthostatic Hypotension1

Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.